Basic Information
Basic information for C8orf34-AS1-201-21aa
Peptide Name C8orf34-AS1-201-21aa
Genome Position chr8:68303506-68303534,68306565-68306598[-]
Species Human
Peptide Sequence MKVKTGALITHGSHFVAQAGV
Peptide Length 21
Unique No (C8orf34-AS1-202-21aa,C8orf34-AS1-203-21aa,C8orf34-AS1-204-21aa,C8orf34-AS1-205-21aa,C8orf34-AS1-206-21aa,C8orf34-AS1-207-21aa,C8orf34-AS1-208-21aa,C8orf34-AS1-209-21aa,C8orf34-AS1-210-21aa-2)
Grand Average of Hydropathicity 0.4714
Relative Molecular Mass 2512.93
Experimental Evidences 2:lncORF,ribo
lncRNA ID/Name ENSG00000248801;C8orf34-AS1
Transcript ID/Name ENST00000512294;C8orf34-AS1-201
Transcript Length 1684
Coding Ability 0.2898
DNA Sequence Corresponding to Peptide ATGAAGGTGAAGACTGGAGCACTCATCACCCACGGGTCTCACTTTGTTGCCCAGGCTGGAGTA
Experimental Evidences
   lncORF
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :